−0.005AUD
−9.15 MAUD
914.97 KAUD
1.25 B
About BOTANIX PHARMACEUTICALS LTD
Sector
CEO
Howie McKibbon
Headquarters
Leederville
Website
Founded
1984
ISIN
AU000000BOT2
FIGI
BBG000BB1YZ8
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the business of researching and developing dermatology and antimicrobial products. It operates under the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in Leederville, Australia.
testig out BOT and saving here for recordsjust how i think it could possibly play out... I think it'll stay above 0.19 but lets see
0.28 and beyondUpcoming FDA approval should see BOT finally get to 0.28 and above... Just a very basic channel i am following.
BOT - Wyckoff Accumulation SchematicPotentially accumulating right now, publishing so that I can follow to see what happens on this one! Note that I've charted using Heikin Ashi as it paints a clearer picture on this. I've drawn roughly what you'd expect to see from here if we are in an accumulation range.
Phase A:
The Preliminary
Bullish potential detected for BOTFollowing a few stocks in the ASX of particular interest, BOT represents a potential bullish opportunity should momentum continue and higher highs and higher lows be made past the current position. I'll cover this more in the upcoming weekly video, however as can be seen in the chart, the stock pric
Key point on BOT - where to? Couple of things to unpack here, we're at a Pivotal point right now just holding the .618 Fibonacci retracement level on the recent move.
DOW Theory suggests "The secondary, or intermediate, trend represents corrections in the primary trend and usually lasts three weeks to three months. These inte
Botanix: Dead Cat Bounce?Recent events have caused what was a 'guaranteed' FDA approval price-pump to fall 40+% at their low (so far) with FDA requiring additional 'Patient Instruction update'.
I'm looking for a short term move back to .14-.15 on bullish divergence, bearing in mind there's a much larger hidden bearish div
ASX Top 10 Momentum Stocks: 21 August 2023 - Finer Market PointsASX:LDX ASX:LU7 FWB:LLI ASX:WC8 ASX:AW1 NYSE:ROG ASX:BOT ASX:GCY NYSE:ARL ASX:IR1
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appearing
ASX Top 10 Momentum Stocks: 15 August 2023 - Finer Market PointsASX:AW1 ASX:WC8 ASX:LDX ASX:AZS ASX:RDX ASX:BOT FWB:CCX NASDAQ:LNW ASX:IR1 NASDAQ:NXL
Momentum leading shares are the market's best performers today. They are the fastest-growing shares on the ASX over the last 90 days. These companies can't get to be leaders without first appear
BOT -updatemade our targets and now BOT has pulled back some what to 0.073 - 0.074 range. Will hopeufly bounce around here for a short period before breaking through 0.078 and into 0.084 area
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BOT is 0.225 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BOTANIX PHARMACEUTICALS LTD stocks are traded under the ticker BOT.
BOTANIX PHARMACEUTICALS LTD is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
BOT stock is 5.45% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is BOTANIX PHARMACEUTICALS LTD there?
One year price forecast for BOTANIX PHARMACEUTICALS LTD has a max estimate of 0.300 AUD and a min estimate of 0.300 AUD.
Yes, you can track BOTANIX PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
BOT stock has risen by 7.14% compared to the previous week, the month change is a 15.38% rise, over the last year BOTANIX PHARMACEUTICALS LTD has showed a 136.84% increase.
BOT net income for the last quarter is −5.47 M AUD, while the quarter before that showed −4.56 M AUD of net income which accounts for −19.97% change. Track more BOTANIX PHARMACEUTICALS LTD financial stats to get the full picture.
Today BOTANIX PHARMACEUTICALS LTD has the market capitalization of 354.41 M, it has decreased by 4.26% over the last week.
No, BOT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOTANIX PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOTANIX PHARMACEUTICALS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOTANIX PHARMACEUTICALS LTD stock shows the buy signal. See more of BOTANIX PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BOTANIX PHARMACEUTICALS LTD future price: according to them, BOT price has a max estimate of 0.30 AUD and a min estimate of 0.30 AUD. Read a more detailed BOTANIX PHARMACEUTICALS LTD forecast: see what analysts think of BOTANIX PHARMACEUTICALS LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOTANIX PHARMACEUTICALS LTD EBITDA is −9.94 M AUD, and current EBITDA margin is −1.39 K%. See more stats in BOTANIX PHARMACEUTICALS LTD financial statements.